Omrani, A.S., Alfahad, W.A., Shoukri, M.M., Baadani, A.M., Aldalbahi, S., Almitwazi, A.A., et al. (2015) High Dose Intravenous Colistin Methanesulfonate Therapy Is Associated with High Rates of Nephrotoxicity: A Prospective Cohort Study from Saudi Arabia. Annals of Clinical Microbiology and Antimicrobials, 14, 3.
https://doi.org/10.1186/s12941-015-0062-8

has been cited by the following article:

• TITLE: Colistin Use and Its Resistance in Kingdom of Saudi Arabia: A Narrative Review

  AUTHORS: Hani S. Faidah

  KEYWORDS: Colistin, Clinical Use, Bacterial Resistance, Kingdom of Saudi Arabia

  JOURNAL NAME: Advances in Infectious Diseases, Vol.8 No.4, November 28, 2018

  ABSTRACT: Antibiotic resistance is steadily increasing all over the world and has become a major public health challenge. To this end, colistin, an old bactericidal antibiotic of polymyxins family, has been recently re-introduced as only available last-resort antibiotic arsenal for treatment of infections caused by multidrug resistant (MDR)-Gram-negative bacteria. However, the continual and extensive use of colistin has led to the emergence and rapid spreading of its bacterial resistance and non-susceptibility that is currently experiencing a critical healthcare issue with extensive global concern. Both transferable and intrinsic mechanisms of bacterial resistance to colistin have been documented in several countries and, therefore, comprehensive epidemiological data and reports are urgently needed to better understand the current status of this important antibiotic to properly optimize its clinical significance. In consistency, the present narrative review highlights both clinical use and reported bacterial resistance of colistin in the Kingdom of Saudi Arabia.